TY - JOUR T1 - Predicting Olfactory Loss In Chronic Rhinosinusitis Using Machine Learning JF - medRxiv DO - 10.1101/2020.10.12.20210500 SP - 2020.10.12.20210500 AU - Vijay R. Ramakrishnan AU - Jaron Arbet AU - Jess C. Mace AU - Zachary M. Soler AU - Timothy L. Smith Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/14/2020.10.12.20210500.abstract N2 - Objective Compare machine learning (ML) based predictive analytics methods compared to traditional logistic regression in classification of olfactory dysfunction in chronic rhinosinusitis (CRS-OD), and identify predictors within a large multi-institutional cohort of refractory CRS patients.Methods Adult CRS patients enrolled in a prospective, multi-institutional, observational cohort study were assessed for baseline CRS-OD using a smell identification test (SIT) or brief SIT (bSIT). Four different ML methods were compared to traditional logistic regression for classification of CRS normosmics versus CRS-OD.Results Data were collected for 611 study participants who met inclusion criteria between April 2011 and July 2015. 34% of enrolled patients demonstrated olfactory loss on objective testing. Differences between CRS normosmics and those with smell loss included objective disease measures (CT and endoscopy scores), age, sex, prior surgeries, socioeconomic status, steroid use, polyp presence, asthma, and aspirin sensitivity. Most ML methods outperformed traditional logistic regression in terms of predictive ability. Top predictors include known factors reported in the literature, as well as several socioeconomic factors.Conclusion Olfactory dysfunction is a variable phenomenon within a large multicenter cohort of refractory CRS patients. ML methods outperform traditional logistic regression in classification of normosmia versus smell loss in CRS, and are able to include numerous risk factors into prediction models. These results carry implications for basic science and clinical research in hyposmia secondary to sinonasal disease, the most common cause of persistent olfactory loss in the general population.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT01332136Funding StatementT.L.S., Z.M.S., V.R.R. and J.C.M. are supported by grants for this investigation from the National Institute on Deafness and Other Communication Disorders (NIDCD), one of the National Institutes of Health, Bethesda, MD., USA [R01 DC005805 (T.L.S.) and K23 DC014747 (V.R.R.)].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:COMIRB Protocol 19-2085All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo datasets were generated during the current study. Due to the nature of the primary research study, participants did not agree for their data to be shared publicly, so these supporting data are not available. ER -